SlideShare a Scribd company logo
1 of 1
Gulaba Khan, Victoria Korn, Amreen Patel, and Klarissa Jones
Drew University/ RISE
Stimulation of Platensimycin Production by Inorganic Salts
and Vitamins
BACKGROUND
In the early 1900’s, infectious diseases were
the leading cause of death in the world. It
wasn’t until 1928 that the first medically
useful antibiotic, penicillin, was
discovered. Antibiotic discovery declined
after 1970 within the pharmaceutical
industry and infectious diseases started to
develop resistance to antibiotics. In 2005,
Merck scientists found that the
actinomycete Streptomyces
platensis produced platensimycin, an
antibiotic that inhibits the fatty acid
synthesis II (FASII) pathway in prokaryotes.
Humans only utilize the FASI pathway,
making platensimycin nontoxic to human
beings. Platensimycin has also been found
to be active against resistant pathogens
(including MRSA, VRE, and
Mycobacterium tuberculosis). It also is
active against diabetes.
RESULTS OF THIS YEAR
We continued to study the effects of primary
metabolites, specifically vitamins, on the
production of platensimycin. Of the vitamins
tested, calcium pantothenate and riboflavin
were stimulatory. Calcium pantothenate is
stimulatory because it is a precursor of
Coenzyme A, which is involved as an
activator of several steps in the
platensimycin biosynthetic scheme.
Riboflavin is stimulatory because it is a
precursor of the flavins, FMN and FAD. Two
of the enzymes of platensimycin
biosynthesis are flavin-dependent.
PREVIOUS WORK
Our laboratory group successfully
developed a chemically-defined production
medium (PM7A) that is able to support
antibiotic production by S. platensis. It
contains lactose, glucose, MOPS buffer,
ammonium sulfate at pH 7. In the recent
past, our group has been testing primary
metabolites as possible stimulators of
platensimycin production in this medium. Of
eighteen amino acids tested, only aspartic
acid showed activity.
METHODS
We test for antibiotic production up to 14
days using bioassays. Samples of the
production flasks are removed and paper
disks are dipped into these samples. These
disks are placed on agar plates inoculated
with Staphylococcus aureus. We incubate
these plates at 25-27 degrees overnight and
the next day we observe them and measure
the diameters of clear zones of inhibition
around the disks.
CONCLUSIONS
Examination of the knowledge of
platensimycin biosynthesis offers some
reasons for the activity of our stimulatory
compounds. Specifically, riboflavin is
involved in the biosynthetic pathway.
Pantothenic Acid was seen to have
stimulatory properties as indicated by Figure
1. As demonstrated by the Figure 2, KCl
stimulates antibiotic production. Riboflavin
was also stimulatory as seen as figure 3.
Riboflavin is stimulatory because it is a
precursor of the flavins, FMN and FAD,
which are involved in platensimycin
biosynthesis.
ACKNOWLEDGEMENTS
Special thanks to Dr. A. L Demain, Dr. J
Kettenring, Mira Patel, RISE, DSSI, and
Dr. B Shen of Scripps Institute, Florida.
platensimycin
GOAL OF OUR WORK
Through our work, we hope to learn about
the precursors and/or regulators of the
pathway involved in the production of
platensimycin. Our work is also significant
for future production of this antibiotic, where
information about compounds that stimulate
production could be very useful for
commercial production.
FUTURE WORK
● Determine the effects of purines and
pyrimidines on platensimycin
biosynthesis.
● Determine effects of positive compounds
on a high-producing mutant of
Streptomyces platensis.
Stimulation by Pantothenic Acid
PM7A
100X Pantothenic Acid+ PM7A
1000X Pantothenic Acid+ PM7A
Stimulation by KCl
KCl+ PM7A
PM7A
Stimulation by Riboflavin
Riboflavin + PM7A
PM7A
Figure 1
Figure 3
Figure 2

More Related Content

What's hot

Penicillin fermentation[1]
Penicillin fermentation[1]Penicillin fermentation[1]
Penicillin fermentation[1]Akshitakapadia
 
Discolouration modification by genetic engineering ppt for students
Discolouration modification by genetic engineering ppt for students  Discolouration modification by genetic engineering ppt for students
Discolouration modification by genetic engineering ppt for students thirupathiSathya
 
Bacteriocin based strategy for enhaced food safety
Bacteriocin based strategy for enhaced food safetyBacteriocin based strategy for enhaced food safety
Bacteriocin based strategy for enhaced food safetyDiwas Pradhan
 
Antibiotics: Penicillin
Antibiotics:  PenicillinAntibiotics:  Penicillin
Antibiotics: Penicillinhvshahare
 
Antibiotic Groups - β-lactams
Antibiotic Groups - β-lactamsAntibiotic Groups - β-lactams
Antibiotic Groups - β-lactamsOssama Motawae
 
Penicillin full information
Penicillin full informationPenicillin full information
Penicillin full informationRAKESH Choudhary
 
Antibiotic production
Antibiotic productionAntibiotic production
Antibiotic productionRinaldo John
 
Production of antibiotics
Production of antibioticsProduction of antibiotics
Production of antibioticsBappa Nondi
 

What's hot (11)

Penicillin fermentation[1]
Penicillin fermentation[1]Penicillin fermentation[1]
Penicillin fermentation[1]
 
Discolouration modification by genetic engineering ppt for students
Discolouration modification by genetic engineering ppt for students  Discolouration modification by genetic engineering ppt for students
Discolouration modification by genetic engineering ppt for students
 
Bacteriocin based strategy for enhaced food safety
Bacteriocin based strategy for enhaced food safetyBacteriocin based strategy for enhaced food safety
Bacteriocin based strategy for enhaced food safety
 
Antibiotics: Penicillin
Antibiotics:  PenicillinAntibiotics:  Penicillin
Antibiotics: Penicillin
 
Antibiotic Groups - β-lactams
Antibiotic Groups - β-lactamsAntibiotic Groups - β-lactams
Antibiotic Groups - β-lactams
 
Penicillin full information
Penicillin full informationPenicillin full information
Penicillin full information
 
Antibiotic production
Antibiotic productionAntibiotic production
Antibiotic production
 
Penicillin
Penicillin Penicillin
Penicillin
 
Production of antibiotics
Production of antibioticsProduction of antibiotics
Production of antibiotics
 
Lantibiotic
LantibioticLantibiotic
Lantibiotic
 
Penicillin
PenicillinPenicillin
Penicillin
 

Similar to DSSI Poster Final

ARTICLEdoi10.1038nature14098A new antibiotic kills pat.docx
ARTICLEdoi10.1038nature14098A new antibiotic kills pat.docxARTICLEdoi10.1038nature14098A new antibiotic kills pat.docx
ARTICLEdoi10.1038nature14098A new antibiotic kills pat.docxdavezstarr61655
 
ANTIBIOTICS (Tetracycline)
ANTIBIOTICS (Tetracycline)ANTIBIOTICS (Tetracycline)
ANTIBIOTICS (Tetracycline)Esam Yahya
 
Antibiotics /cosmetic dentistry courses
Antibiotics /cosmetic dentistry coursesAntibiotics /cosmetic dentistry courses
Antibiotics /cosmetic dentistry coursesIndian dental academy
 
Van tinh nguyen chapter 39-anticancer drugs
Van tinh nguyen chapter 39-anticancer drugsVan tinh nguyen chapter 39-anticancer drugs
Van tinh nguyen chapter 39-anticancer drugsDimpled ĐồngTiền
 
Pharmacology II Chapter 1 ppt -.pptx
Pharmacology II Chapter 1 ppt -.pptxPharmacology II Chapter 1 ppt -.pptx
Pharmacology II Chapter 1 ppt -.pptxHaseebaKhan10
 
Group 5 drug design assignment. amoxicillin
Group 5 drug design assignment. amoxicillinGroup 5 drug design assignment. amoxicillin
Group 5 drug design assignment. amoxicillinMINANI Theobald
 
Drug design presentation. amoxils
Drug design presentation. amoxilsDrug design presentation. amoxils
Drug design presentation. amoxilsMINANI Theobald
 
Cell Wall Inhibitors
Cell Wall InhibitorsCell Wall Inhibitors
Cell Wall Inhibitorsshabeel pn
 
Story of penicillin
Story of penicillinStory of penicillin
Story of penicillinAnupama Paul
 
181550 181550-181550-181550-ibds (1)
181550 181550-181550-181550-ibds (1)181550 181550-181550-181550-ibds (1)
181550 181550-181550-181550-ibds (1)wuokanyi
 
Laminine LPGN - lekarstven spravochnik USA 2015
Laminine LPGN - lekarstven spravochnik  USA 2015Laminine LPGN - lekarstven spravochnik  USA 2015
Laminine LPGN - lekarstven spravochnik USA 2015vili9
 
antibiotic resistance.pptx
antibiotic resistance.pptxantibiotic resistance.pptx
antibiotic resistance.pptxDicksonDaniel7
 
Medicinal chemistry introduction history,scope .pdf
Medicinal chemistry introduction history,scope .pdfMedicinal chemistry introduction history,scope .pdf
Medicinal chemistry introduction history,scope .pdfVishalpatil739232
 
Eubioflor aplicado en recién nacidos para regular la flora intestinal Scerbacova
Eubioflor aplicado en recién nacidos para regular la flora intestinal ScerbacovaEubioflor aplicado en recién nacidos para regular la flora intestinal Scerbacova
Eubioflor aplicado en recién nacidos para regular la flora intestinal ScerbacovaNaturpharma (Medicina Biológica)
 
Final work alejandra & nicole
Final work alejandra & nicoleFinal work alejandra & nicole
Final work alejandra & nicoleNicole Rivera
 

Similar to DSSI Poster Final (20)

ANTIBIOTICS
ANTIBIOTICSANTIBIOTICS
ANTIBIOTICS
 
ARTICLEdoi10.1038nature14098A new antibiotic kills pat.docx
ARTICLEdoi10.1038nature14098A new antibiotic kills pat.docxARTICLEdoi10.1038nature14098A new antibiotic kills pat.docx
ARTICLEdoi10.1038nature14098A new antibiotic kills pat.docx
 
Antibiotic
AntibioticAntibiotic
Antibiotic
 
1. INTRODUCTION OF CHEMOTHERAPY
1. INTRODUCTION OF CHEMOTHERAPY1. INTRODUCTION OF CHEMOTHERAPY
1. INTRODUCTION OF CHEMOTHERAPY
 
ANTIBIOTICS (Tetracycline)
ANTIBIOTICS (Tetracycline)ANTIBIOTICS (Tetracycline)
ANTIBIOTICS (Tetracycline)
 
Antibiotics /cosmetic dentistry courses
Antibiotics /cosmetic dentistry coursesAntibiotics /cosmetic dentistry courses
Antibiotics /cosmetic dentistry courses
 
Antioxidanti 2
Antioxidanti 2Antioxidanti 2
Antioxidanti 2
 
Antibiotics.pptx
Antibiotics.pptxAntibiotics.pptx
Antibiotics.pptx
 
Van tinh nguyen chapter 39-anticancer drugs
Van tinh nguyen chapter 39-anticancer drugsVan tinh nguyen chapter 39-anticancer drugs
Van tinh nguyen chapter 39-anticancer drugs
 
Pharmacology II Chapter 1 ppt -.pptx
Pharmacology II Chapter 1 ppt -.pptxPharmacology II Chapter 1 ppt -.pptx
Pharmacology II Chapter 1 ppt -.pptx
 
Group 5 drug design assignment. amoxicillin
Group 5 drug design assignment. amoxicillinGroup 5 drug design assignment. amoxicillin
Group 5 drug design assignment. amoxicillin
 
Drug design presentation. amoxils
Drug design presentation. amoxilsDrug design presentation. amoxils
Drug design presentation. amoxils
 
Cell Wall Inhibitors
Cell Wall InhibitorsCell Wall Inhibitors
Cell Wall Inhibitors
 
Story of penicillin
Story of penicillinStory of penicillin
Story of penicillin
 
181550 181550-181550-181550-ibds (1)
181550 181550-181550-181550-ibds (1)181550 181550-181550-181550-ibds (1)
181550 181550-181550-181550-ibds (1)
 
Laminine LPGN - lekarstven spravochnik USA 2015
Laminine LPGN - lekarstven spravochnik  USA 2015Laminine LPGN - lekarstven spravochnik  USA 2015
Laminine LPGN - lekarstven spravochnik USA 2015
 
antibiotic resistance.pptx
antibiotic resistance.pptxantibiotic resistance.pptx
antibiotic resistance.pptx
 
Medicinal chemistry introduction history,scope .pdf
Medicinal chemistry introduction history,scope .pdfMedicinal chemistry introduction history,scope .pdf
Medicinal chemistry introduction history,scope .pdf
 
Eubioflor aplicado en recién nacidos para regular la flora intestinal Scerbacova
Eubioflor aplicado en recién nacidos para regular la flora intestinal ScerbacovaEubioflor aplicado en recién nacidos para regular la flora intestinal Scerbacova
Eubioflor aplicado en recién nacidos para regular la flora intestinal Scerbacova
 
Final work alejandra & nicole
Final work alejandra & nicoleFinal work alejandra & nicole
Final work alejandra & nicole
 

DSSI Poster Final

  • 1. Gulaba Khan, Victoria Korn, Amreen Patel, and Klarissa Jones Drew University/ RISE Stimulation of Platensimycin Production by Inorganic Salts and Vitamins BACKGROUND In the early 1900’s, infectious diseases were the leading cause of death in the world. It wasn’t until 1928 that the first medically useful antibiotic, penicillin, was discovered. Antibiotic discovery declined after 1970 within the pharmaceutical industry and infectious diseases started to develop resistance to antibiotics. In 2005, Merck scientists found that the actinomycete Streptomyces platensis produced platensimycin, an antibiotic that inhibits the fatty acid synthesis II (FASII) pathway in prokaryotes. Humans only utilize the FASI pathway, making platensimycin nontoxic to human beings. Platensimycin has also been found to be active against resistant pathogens (including MRSA, VRE, and Mycobacterium tuberculosis). It also is active against diabetes. RESULTS OF THIS YEAR We continued to study the effects of primary metabolites, specifically vitamins, on the production of platensimycin. Of the vitamins tested, calcium pantothenate and riboflavin were stimulatory. Calcium pantothenate is stimulatory because it is a precursor of Coenzyme A, which is involved as an activator of several steps in the platensimycin biosynthetic scheme. Riboflavin is stimulatory because it is a precursor of the flavins, FMN and FAD. Two of the enzymes of platensimycin biosynthesis are flavin-dependent. PREVIOUS WORK Our laboratory group successfully developed a chemically-defined production medium (PM7A) that is able to support antibiotic production by S. platensis. It contains lactose, glucose, MOPS buffer, ammonium sulfate at pH 7. In the recent past, our group has been testing primary metabolites as possible stimulators of platensimycin production in this medium. Of eighteen amino acids tested, only aspartic acid showed activity. METHODS We test for antibiotic production up to 14 days using bioassays. Samples of the production flasks are removed and paper disks are dipped into these samples. These disks are placed on agar plates inoculated with Staphylococcus aureus. We incubate these plates at 25-27 degrees overnight and the next day we observe them and measure the diameters of clear zones of inhibition around the disks. CONCLUSIONS Examination of the knowledge of platensimycin biosynthesis offers some reasons for the activity of our stimulatory compounds. Specifically, riboflavin is involved in the biosynthetic pathway. Pantothenic Acid was seen to have stimulatory properties as indicated by Figure 1. As demonstrated by the Figure 2, KCl stimulates antibiotic production. Riboflavin was also stimulatory as seen as figure 3. Riboflavin is stimulatory because it is a precursor of the flavins, FMN and FAD, which are involved in platensimycin biosynthesis. ACKNOWLEDGEMENTS Special thanks to Dr. A. L Demain, Dr. J Kettenring, Mira Patel, RISE, DSSI, and Dr. B Shen of Scripps Institute, Florida. platensimycin GOAL OF OUR WORK Through our work, we hope to learn about the precursors and/or regulators of the pathway involved in the production of platensimycin. Our work is also significant for future production of this antibiotic, where information about compounds that stimulate production could be very useful for commercial production. FUTURE WORK ● Determine the effects of purines and pyrimidines on platensimycin biosynthesis. ● Determine effects of positive compounds on a high-producing mutant of Streptomyces platensis. Stimulation by Pantothenic Acid PM7A 100X Pantothenic Acid+ PM7A 1000X Pantothenic Acid+ PM7A Stimulation by KCl KCl+ PM7A PM7A Stimulation by Riboflavin Riboflavin + PM7A PM7A Figure 1 Figure 3 Figure 2